U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT06918743) titled 'To Evaluate the Efficacy and Safety of RSS0393 Ointment in Patients With Plaque Psoriasis Phase II Study' on March 24.
Brief Summary: To evaluate the efficacy and safety of RSS0393 ointment in patients with plaque psoriasis Phase II study
Study Start Date: April, 2025
Study Type: INTERVENTIONAL
Condition:
Psoriatic Subjects
Intervention:
DRUG: RSS0393 ointment
RSS0393 ointment 0.01%
DRUG: RSS0393 ointment
RSS0393 ointment 0.03%
DRUG: RSS0393 ointment placebo
RSS0393 ointment placebo
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Published by HT Digital Content Services with permissi...